Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -3.45%2.58B | ---- | -29.55%3B | ---- | -8.68%2.67B | ---- | 0.14%4.26B | ---- | 6.29%2.92B |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -40.52%-231.49M | ---- | -28.70%-321.83M | ---- | 6.62%-164.74M | ---- | 40.63%-250.07M | ---- | -218.71%-176.42M |
| Impairment and provisions: | ---- | 85.87%155.1M | ---- | 442.99%470.58M | ---- | -13.50%83.44M | ---- | 63.12%86.67M | ---- | 340.90%96.47M |
| -Other impairments and provisions | ---- | 80.58%148.31M | ---- | -23.87%63.3M | ---- | -18.27%82.13M | ---- | 84.17%83.14M | ---- | 389.23%100.49M |
| Revaluation surplus: | ---- | 2,662.43%11.42M | ---- | 36.19%-24.65M | ---- | 98.99%-445.75K | ---- | -1,175.97%-38.64M | ---- | -4,726.36%-44.05M |
| Asset sale loss (gain): | ---- | -1,139.80%-3.63M | ---- | 7.55%-11.12M | ---- | 33.40%-293K | ---- | -1,643.51%-12.03M | ---- | 20.73%-439.94K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -1,139.80%-3.63M | ---- | 7.55%-11.12M | ---- | 33.40%-293K | ---- | -1,643.51%-12.03M | ---- | 20.73%-439.94K |
| Depreciation and amortization: | ---- | -0.74%478.04M | ---- | -4.99%936.2M | ---- | -10.61%481.61M | ---- | 24.15%985.32M | ---- | 44.10%538.81M |
| -Amortization of intangible assets | ---- | -7.02%37.59M | ---- | -17.06%78.58M | ---- | -16.72%40.43M | ---- | 22.17%94.74M | ---- | 38.31%48.55M |
| -Other depreciation and amortization | ---- | 4.45%32.56M | ---- | 9.08%60.96M | ---- | 20.83%31.17M | ---- | 12.15%55.88M | ---- | 20.95%25.8M |
| Financial expense | ---- | -4.38%204M | ---- | -6.28%418.15M | ---- | -5.37%213.35M | ---- | 2.71%446.19M | ---- | 8.41%225.45M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 96.88%1.49B | ---- | -57.35%-1.31B | ---- | -50.19%754.94M | ---- | -244.74%-835.03M | ---- | -32.50%1.52B |
| Accounts receivable (increase)decrease | ---- | -81.24%-4.09B | ---- | 38.67%-255.91M | ---- | -69.98%-2.26B | ---- | 79.05%-417.27M | ---- | -36.04%-1.33B |
| Accounts payable increase (decrease) | ---- | -4.75%-3.96B | ---- | 1,011.52%602.7M | ---- | 16.20%-3.78B | ---- | -101.60%-66.12M | ---- | -58.76%-4.51B |
| Special items of business | ---- | 37.97%-23.58M | ---- | -6.95%-58.53M | ---- | -329.75%-38.01M | ---- | -1,253.30%-54.72M | ---- | 203.49%16.54M |
| Adjustment items of business operations | -162.45%-1.97B | -68.78%-3.37B | -24.19%-3.9B | -15.81%3.5B | -183.33%-751.36M | -163.95%-2B | -10.54%-3.14B | -40.62%4.16B | -72.67%901.63M | -143.82%-757.25M |
| Net cash from operations | -162.45%-1.97B | -66.79%-3.4B | -24.19%-3.9B | -16.11%3.44B | -183.33%-751.36M | -174.97%-2.04B | -10.54%-3.14B | -41.37%4.1B | -72.67%901.63M | -143.26%-740.71M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 261.36%387.65M | 27.91%81.3M | 93.36%63.22M | -43.79%216.09M | -67.83%107.28M | -68.13%63.56M | -55.77%32.7M | 78.98%384.43M | 123.39%333.46M | 1,432.45%199.46M |
| Sale of fixed assets | 501.19%6.4M | 675.33%5.86M | 85.87%148.77K | -83.06%2.36M | -83.43%1.06M | -85.18%756.37K | -79.99%80.04K | 832.27%13.93M | 425.24%6.42M | 369.26%5.1M |
| Purchase of fixed assets | -11.98%-909.28M | 11.95%-497.21M | 28.95%-226.5M | 30.72%-1.13B | 29.83%-811.98M | 25.63%-564.67M | -35.74%-318.77M | -17.67%-1.63B | -28.82%-1.16B | -37.91%-759.29M |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---1.57M | ---1.57M | ---1.57M | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | 1,024.55%6.63B | 1,333.28%1.65B | 1,440.02%662.21M | -38.33%1.49B | -70.80%590M | -91.23%115M | -79.49%43M | 253.66%2.42B | 1,867.55%2.02B | 1,469.80%1.31B |
| Cash on investment | -131.34%-9.54B | -69.01%-5.96B | -3,000.00%-1.24B | -52.01%-6.55B | -20.91%-4.12B | -106.15%-3.53B | 94.18%-40M | 37.75%-4.31B | 34.74%-3.41B | 21.34%-1.71B |
| Other items in the investment business | 123,614.37%1.29M | 124,052.73%1.29M | --2.26M | -96.76%1.11K | 100.08%1.04K | -96.77%1.04K | ---- | -99.98%34.27K | -6,060.52%-1.28M | 128.90%32.06K |
| Net cash from investment operations | 19.31%-3.42B | -20.64%-4.72B | -161.01%-738.65M | -91.47%-5.96B | -91.92%-4.24B | -309.84%-3.91B | 55.65%-283M | 57.06%-3.11B | 62.39%-2.21B | 63.69%-955.18M |
| Net cash before financing | -8.05%-5.39B | -36.44%-8.12B | -35.51%-4.64B | -355.02%-2.52B | -281.72%-4.99B | -250.93%-5.95B | 1.60%-3.42B | 489.11%988.77M | 49.21%-1.31B | -84.69%-1.7B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 14.47%9.73B | 16.04%8.2B | -18.01%4.31B | 3.64%9.95B | 9.94%8.5B | 8.98%7.06B | -0.76%5.25B | -0.95%9.6B | -8.38%7.73B | 8.14%6.48B |
| Refund | -29.24%-7.99B | -8.81%-5.54B | 3.59%-3.13B | 10.53%-8.39B | 11.48%-6.18B | -7.99%-5.09B | 10.55%-3.25B | -15.06%-9.38B | -13.78%-6.99B | -2.02%-4.72B |
| Dividends paid - financing | -2.70%-1.59B | 39.43%-751.41M | -7.30%-89.36M | -44.73%-2.32B | -4.82%-1.55B | -2.34%-1.24B | 7.40%-83.29M | -3.85%-1.61B | -3.76%-1.48B | -5.76%-1.21B |
| Absorb investment income | 382.06%150.21M | 513.68%130.1M | ---- | 105.21%40.96M | 56.11%31.16M | 6.21%21.2M | --5.21M | -38.87%19.96M | 1,591.53%19.96M | --19.96M |
| Other items of the financing business | 428.77%704.81M | 26.34%-115.2M | -515.26%-58.75M | 53.65%-286.67M | -3.02%-214.38M | -253.90%-156.39M | 1,930.50%14.15M | -4,481.09%-618.49M | -150.51%-208.09M | -88.31%101.62M |
| Net cash from financing operations | 71.35%1.01B | 222.36%1.92B | -47.12%1.03B | 49.13%-1.01B | 164.06%587.31M | -11.84%595.08M | 23.43%1.94B | -4,404.70%-1.98B | -171.00%-916.78M | -38.33%674.99M |
| Effect of rate | -18.85%4.07M | 27.77%5.47M | 160.19%6.33M | -11.69%7.14M | -25.79%5.01M | 13.76%4.28M | 35.31%2.43M | 1,705.51%8.08M | 870.49%6.75M | -28.05%3.76M |
| Net Cash | 0.39%-4.39B | -15.78%-6.2B | -143.68%-3.61B | -256.61%-3.53B | -97.99%-4.4B | -424.67%-5.36B | 22.25%-1.48B | -375.22%-989.24M | -73.36%-2.22B | -679.08%-1.02B |
| Begining period cash | -17.76%16.3B | -17.76%16.3B | -17.76%16.3B | -4.72%19.82B | -4.72%19.82B | -4.72%19.82B | -4.72%19.82B | -0.99%20.8B | -0.99%20.8B | -0.99%20.8B |
| Cash at the end | -22.72%11.92B | -30.16%10.11B | -30.77%12.7B | -17.76%16.3B | -17.01%15.42B | -26.87%14.47B | -2.94%18.34B | -4.72%19.82B | -5.79%18.59B | -6.64%19.79B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.